Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
univercells.com was registered 1 decade 1 year ago. It has a alexa rank of #5,747,357 in the world. It is a domain having .com extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, univercells.com is SAFE to browse.
Daily Unique Visitors: | 153 |
Daily Pageviews: | 306 |
Income Per Day: | $ 1.00 |
Estimated Worth: | $ 240.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 5,747,357 |
PageSpeed Score: | 89 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Univercells. www.univercells.com. Rue Auguste Piccard 48. Gosselies 6490. Belgium +32 2 318 83 48. Activities. Pharmaceuticals. Related Content. Exyte and ...
Univercells is a technology company offering novel biomanufacturing platforms, aimed at increasing the availability and affordability of biologics recombinant ...
Univercells was founded in 2013 by experienced entrepreneurs Hugues Bultot, CEO, and José Castillo, CTO, who bring close to 25 years of expertise in the ...
Univercells has 142 employees across 3 locations and $37.71 m in total funding,. See insights on Univercells including office locations, competitors, revenue, ...
Feb 18, 2020 ... Univercells, an innovative bioprocessing provider focused on increasing the availability of affordable biologics to address global health ...
Univercells SA ('Univercells') is pleased to announce the closing of a €16 million ($18.8 million) Series B equity financing. Investment proceeds will support the ...
UNIVERCELLS uses 0 email formats: . Enter a name to find & verify an email >>>
UNIVERCELLS provides innovative biomanufacturing platforms and solutions to make biological products accessible and affordable for all. This Belgian ...
Univercells, designing biological solutions for healthcare providers. Here you'll find information about their funding, investors and team.
Univercells delivers novel biomanufacturing platforms and solutions aiming at making biologics available & affordable to all.
Univercells. Univercells uses advanced manufacturing technologies to make " Biologics for all." Invested: 2020. Modality: Process Innovation.
Univercells's top competitors include Aglaris, Biospherix and Cell Culture Company. See the full list of Univercells competitors, plus revenue, employees, and ...
Univercells and consortium partners Batavia Biosciences and Natrix Separations selected by Bill & Melinda Gates Foundation to Radically Reduce Vaccine ...
Home · Our members; Univercells. Charleroi | Sustaining. Entrepreneurial holding with industrial expertise in bioprocess translated into novel products, services, ...
Univercells SA, Brussels - Cited by 156 - Vaccine manufacturing - Gene therapy - Corporate Development
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end- to-end" solutions, with innovative engineering able to decrease the needs for ...
Univercells Technologies is a global provider of innovative biomanufacturing technologies to achieve cost-effective viral production from R&D to commercial ...
Univercells is a medical engineering company having developed technologies aiming at reducing the cost of vaccines and biologics by significant factors.
José Castillo, PhD, CTO & co-founder of Univercells ... Univercells is offering disruptive manufacturing platforms based on innovative upstream and downstream.
660 (both UNIVERCELLS SA and EXOTHERA SA collectively hereafter referred to as “Univercells Group Group”). HEADQUARTERS & BIOPROCESS DESIGN ...
H1 Headings: | 1 | H2 Headings: | 11 |
H3 Headings: | 17 | H4 Headings: | 1 |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 10 |
Google Adsense: | Not Applicable | Google Analytics: | UA-110473784-1 |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
us on | 6 | 0.702 % | No |
twittercomiwebstatus1… BiologicsforAll | 6 | 0.702 % | No |
Visit us | 6 | 0.702 % | No |
Press release | 5 | 0.585 % | No |
the website | 5 | 0.585 % | No |
twittercomiwebstatus1… Retweeted | 4 | 0.468 % | No |
cookies that | 4 | 0.468 % | No |
Manufacturing Technologies | 4 | 0.468 % | No |
by Univercells | 4 | 0.468 % | No |
for the | 4 | 0.468 % | No |
these cookies | 4 | 0.468 % | No |
Learn more | 4 | 0.468 % | No |
Retweeted by | 4 | 0.468 % | No |
Posted on | 3 | 0.351 % | No |
for all | 3 | 0.351 % | No |
Newsroom Contact | 3 | 0.351 % | No |
Univercells BiologicsforAll | 3 | 0.351 % | No |
Technologies Vaccines | 3 | 0.351 % | No |
on your | 3 | 0.351 % | No |
release Univercells | 3 | 0.351 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
twittercomiwebstatus1… Retweeted by Univercells | 4 | 0.468 % | No |
Manufacturing Technologies Vaccines Biosimilars | 3 | 0.351 % | No |
Technologies Vaccines Biosimilars Careers | 3 | 0.351 % | No |
Retweeted by Univercells BiologicsforAll | 3 | 0.351 % | No |
projects in Senegal strengthening | 2 | 0.234 % | No |
in Senegal strengthening BelgoSenegalese | 2 | 0.234 % | No |
access to biologics for | 2 | 0.234 % | No |
bioproduction projects in Senegal | 2 | 0.234 % | No |
two bioproduction projects in | 2 | 0.234 % | No |
Intent for two bioproduction | 2 | 0.234 % | No |
for two bioproduction projects | 2 | 0.234 % | No |
advance access to biologics | 2 | 0.234 % | No |
the barriers to bioproduction | 2 | 0.234 % | No |
collaborations to advance access | 2 | 0.234 % | No |
website uses cookies to | 2 | 0.234 % | No |
BelgoSenegalese collaborations to advance | 2 | 0.234 % | No |
to advance access to | 2 | 0.234 % | No |
strengthening BelgoSenegalese collaborations to | 2 | 0.234 % | No |
of Intent for two | 2 | 0.234 % | No |
This website uses cookies | 2 | 0.234 % | No |
Domain Registrar: | OVH sas |
---|---|
Registration Date: | 2012-12-11 1 decade 1 year 11 months ago |
Last Modified: | 2020-12-02 3 years 11 months 2 weeks ago |
Host | Type | TTL | Extra |
---|---|---|---|
univercells.com | A | 86395 |
IP: 51.83.46.151 |
univercells.com | NS | 86400 |
Target: dns103.ovh.net |
univercells.com | NS | 86400 |
Target: ns103.ovh.net |
univercells.com | SOA | 86400 |
MNAME: dns103.ovh.net RNAME: tech.ovh.net Serial: 2021021800 Refresh: 86400 Retry: 3600 Expire: 3600000 |
univercells.com | MX | 300 |
Target: esa1.hc629-62.eu.iphmx.com |
univercells.com | MX | 300 |
Priority: 10 Target: esa2.hc629-62.eu.iphmx.com |
univercells.com | TXT | 86400 |
TXT: keakki989l04vn4ht0cj31m8g1 |
univercells.com | TXT | 86400 |
TXT: MS=ms15740666 |
univercells.com | TXT | 86400 |
TXT: v=spf1 ip4:23.90.102.85 ip4:23.90.105.56 ip4:195.238.20.128 include:spf.protection.outlook.com include:eu.transmail.net -all |
univercells.com | TXT | 86400 |
TXT: google-site-verification=Jn6ROXeeqc2Or9J ZOxWOhRf7xvMMAQsxiteZR0bzqv0 |
ZAS was established in 1984 as a Canadian Architectural partnership. Since 2004 the Enterprise has diversified to offer expertise in areas of Real estate Development, IT...
Fleur de Café is de specialist op het gebied van koffie & thee | losse thee ✔ (on)gebrande koffiebonen ✔ koffie- & espressomachines ✔
Comparez les services sur internet